Flippin Bruce & Porter’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$9.69M Sell
153,528
-1,379
-0.9% -$85.8K 1.75% 25
2020
Q4
$9.61M Sell
154,907
-3,101
-2% -$191K 1.9% 21
2020
Q3
$9.53M Sell
158,008
-5,698
-3% -$343K 2.14% 18
2020
Q2
$9.63M Buy
163,706
+40,400
+33% +$2.42M 2.16% 14
2020
Q1
$6.87M Buy
123,306
+832
+0.7% +$50.9K 1.68% 23
2019
Q4
$7.86M Sell
122,474
-550
-0.4% -$31.5K 1.36% 38
2019
Q3
$6.24M Sell
123,024
-1,400
-1% -$65.8K 1.11% 46
2019
Q2
$5.64M Buy
+124,424
New +$5.8M 0.99% 50

Other funds holding BMY

Flippin Bruce & Porter's BMY Position: Q1 2021 in Review

Flippin Bruce & Porter reduced its Bristol-Myers Squibb (BMY) stake by 0.89% in Q1 2021, selling an estimated $85.8K and leaving 153,528 shares worth $9.69M. The position accounts for 1.75% of the portfolio, ranked #25.

Flippin Bruce & Porter first reported a position in BMY in Q2 2019 and has held it in 8 quarters since. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Flippin Bruce & Porter held 153,528 shares of Bristol-Myers Squibb worth $9.69M as of Q1 2021.
  • Flippin Bruce & Porter sold 1,379 Bristol-Myers Squibb shares in Q1 2021, an estimated $85.8K.
  • Bristol-Myers Squibb made up 1.75% of Flippin Bruce & Porter's portfolio in Q1 2021, its #25 holding.
  • Flippin Bruce & Porter first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 8 quarters since.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Flippin Bruce & Porter's 13F filing for Q1 2021, filed 4 May 2021.